Relatlimab
Relatlimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Relatlimab is under investigation in clinical trial NCT02966548 (Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors).
| Trade Name | Relatlimab |
| Generic | Relatlimab |
| Relatlimab Other Names | BMS-986016, Relatlimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Relatlimab
